Otto Yang lead investigator in LL inflammation tri
Post# of 148101
(Total Views: 526)
Posted On: 05/30/2024 4:22:50 PM
Otto Yang lead investigator in LL inflammation trial.
Two thoer clinical initiatives:
LATCH trial - HIV Cure for transplant patients. OHSU and Wash U w AMFAR. Transplant costs not paid for by CYDY.
Alzheimer’s treated w LL for 12 weeks. External funding has been secured.
MASH (NASH) combo study with MDGL’s drug in mouse study. Results in the fall.
Two thoer clinical initiatives:
LATCH trial - HIV Cure for transplant patients. OHSU and Wash U w AMFAR. Transplant costs not paid for by CYDY.
Alzheimer’s treated w LL for 12 weeks. External funding has been secured.
MASH (NASH) combo study with MDGL’s drug in mouse study. Results in the fall.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼